Remove Blogging Remove Invest Remove Sales Remove San Diego
article thumbnail

Event Announcement: Xcelerating Life Sciences San Diego

Xconomy

Early bird tickets are on sale now for only $99. Can’t make the San Diego. Grab yours today before prices go up. Each half-day Xcelerating Life Sciences forum is dedicated to helping industry leaders develop meaningful partnerships and explore bold new ideas to overcome healthcare’s biggest challenges.

article thumbnail

Retro: My Favorite Blog Post on Raising VC

Both Sides of the Table

On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Early Bird Sale Ending for San Diego’s Xcelerating Life Sciences Conference

Xconomy

This is the last week to register at the lowest rate for March 18’s Xcelerating Life Sciences: Biomedical Breakthroughs in Precision Medicine & Genomics conference at the Takeda Research facility in San Diego. Hurry, our $99 early bird sale ends this Friday, Feb. 7 at midnight. Speakers include Jay Lichter, CEO of.

article thumbnail

Xconomy Special Report: 12 San Diego Tech Startup to Watch in 2017

Xconomy

I started with a list of companies already screened by the San Diego Venture Group’s annual venture summit, and consulted with investors and startup mentors to refine the list. million in a Series D round of investment capital, according to founder and chairman Tony Farwell. Financial terms were not disclosed.

article thumbnail

With $42M, Ex-Ignyta CEO Aims At Cancer Again With Startup, Erasca

Xconomy

billion sale to Roche , Jonathan Lim is back at it again. Ignyta’s former co-founder and head executive has co-founded another biotech in San Diego, Erasca, which also wants to make new cancer therapies. A year after steering cancer drug developer Ignyta into a $1.7

article thumbnail

Magnolia Medical Captures $20M to Reduce Blood Culture Contamination

Xconomy

Magnolia Medical Technologies , a Seattle-based manufacturer of devices for collecting blood and bodily fluids, announced this week it has raised $20 million in equity funding to ramp up sales of its flagship product. The funding comes as Magnolia and San Diego-based competitor Kurin battle each other in court.

article thumbnail

Profitability Helps San Diego Lender Step Out from Industry Cloud

Xconomy

In contrast to some alternative lenders, the San Diego firm said it is growing fast and is consistently profitable. LendingClub stumbled earlier this year, however, when an internal investigation found improprieties in the sale of $22 million in loans. Reprints | Share: UNDERWRITERS AND PARTNERS.